CSIMarket Company Name, Ticker, Industry, else..


Enlivex Therapeutics Ltd   (NASDAQ: ENLV)
Other Ticker:  
 

Enlivex Therapeutics Ltd

ENLV's Fundamental analysis



Enlivex Therapeutics Ltd 's sales fell in IV. Quarter 2023 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.85 %

Enlivex Therapeutics Ltd net loss decreased from $-31 millions, to $-29 millions in IV. Quarter 2023,

• More on ENLV's Growth


Enlivex Therapeutics Ltd
realized a net loss in trailing twelve months.

Enlivex Therapeutics Ltd realized cash reduction of $ -2.65 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.


• More on ENLV's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.62

Enlivex Therapeutics Ltd
realized net loss in trailing twelve months.

Enlivex Therapeutics Ltd realized cash outflow of $ -2.65per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.

Enlivex Therapeutics Ltd Price to Book Ratio is at 0.55 lower than Industry Avg. of 77.28. and higher than S&P 500 Avg. of 0.01

• More on ENLV's Valuation

•  Market Capitalization (Millions $) 17
•  Shares Outstanding (Millions) 19
•  Employees 29
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -29
•  Cash Flow (TTM) (Millions $) -49
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 1.62

•  Market Capitalization (Millions $) 17
•  Shares Outstanding (Millions) 19
•  Employees 29
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -29
•  Cash Flow (TTM) (Millions $) -49
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 6.99
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.18
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com